Xi'an Central Hospital

The trials here

What the 13 trials at this site are about, from their registry records.

Conditions

• Haemophilia5 trials
• Stroke3 trials
• Immune thrombocytopenia (ITP)2 trials
• Alzheimer disease1 trial
• Irritable bowel syndrome1 trial
• Ulcerative colitis1 trial

Phase

• Phase 35 trials
• Phase 1/22 trials
• Phase 22 trials
• Phase 42 trials
• Phase 2/31 trial

Status

• Completed6 trials
• Active, not recruiting4 trials
• Not yet recruiting2 trials
• Recruiting1 trial

Lead sponsor

• Hangzhou Gensciences Biopharmaceutical Co., Ltd.3 trials
• Jiangsu BioJeTay Biotechnology Co., Ltd.2 trials
• Beijing Hospital of Traditional Chinese Medicine1 trial
• Beijing Tiantan Hospital1 trial
• First Affiliated Hospital of Fujian Medical University1 trial
• and 5 more

Running trials

• Not yet recruiting

  EEG Feedback-Based Vagus Nerve Stimulation for Post-Stroke Dysphagia

  NCT07894315· First Affiliated Hospital of Fujian Medical University· Source

  Contact: Zhengli Di, M.D

• Active, not recruiting

  Study of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein (FRSW107) as Prophylactic Treatment.

  NCT07684898· Phase 3· Hangzhou Gensciences Biopharmaceutical Co., Ltd.· Source

• Not yet recruiting

  Phase III Clinical Trial of Changji'an Capsules in the Treatment of Irritable Bowel Syndrome With Predominant Diarrhea (Liver-Qi Invading Spleen Syndrome)

  NCT07610434· Phase 3· Beijing Hospital of Traditional Chinese Medicine· Source

  Contact: LuQing Zhao, Doctor

• Active, not recruiting

  Study of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein (FRSW107) On-Demand Treatment

  NCT07663903· Phase 3· Hangzhou Gensciences Biopharmaceutical Co., Ltd.· Source

• Recruiting

  A Phase Ib/II Clinical Trial of Multiple Doses of STSA-1301 Subcutaneous Injection in Healthy Subjects and Patients With Immune Thrombocytopenia (ITP)

  NCT06929299· Phase 1/2· Jiangsu BioJeTay Biotechnology Co., Ltd.· Source

  Contact: Yanping Song

• Active, not recruiting

  Phase III Clinical Trial of STSP-0601 for Injection in Hemophilia Patients

  NCT06922045· Phase 3· Jiangsu BioJeTay Biotechnology Co., Ltd.· Source

• Active, not recruiting

  A Clinical Study to Evaluate the Long-Term Safety Sodium Oligomannate Capsules (GV-971)

  NCT05058040· Phase 4· Green Valley (Shanghai) Pharmaceuticals Co., Ltd.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Immune thrombocytopenia (ITP)1 recruiting
• Irritable bowel syndrome1 recruiting
• Stroke1 recruiting

Closed trials

• Completed

  Safety and Efficacy of STSP-0601 in Adult Patients with Hemophilia a or B with Inhibitor

  NCT06289166· Phase 2· Staidson (Beijing) Biopharmaceuticals Co., Ltd· Source

• Completed

  Optimizing Early Nutrition Support in Severe Stroke-2

  NCT05998902· Phase 3· Wen Jiang-3· Source

• Completed

  SS109 and NovoSeven ® PK / PD Profile, and Preliminary Efficacy and Safety of SS109 on Demand Treatment

  NCT06010953· Phase 1/2· Hangzhou Gensciences Biopharmaceutical Co., Ltd.· Source

• Completed

  A Study of SPH3127 in the Treatment of Mild to Moderate Ulcerative Colitis

  NCT05770609· Phase 2· Shanghai Pharmaceuticals Holding Co., Ltd· Source

• Completed

  PROpranolol for Cerebral Hemorrhage-ASsociated pnEumonia (PRO-CHASE)

  NCT05419193· Phase 2/3· Beijing Tiantan Hospital· Source

• Completed

  A Randomized Trial Comparing Optimized rhTPO Treatment With Eltrombopag Treatment in Pre-treated ITP Pts

  NCT05583838· Phase 4· Institute of Hematology & Blood Diseases Hospital, China· Source